Q1 2026 Holdings
Filed 2026-05-15 | 20 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Heartflow Inc(HTFL) | COM | 42238D107 | $254.2M | 10,448,158 | 22.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $233.9M | 7,306,566 | 21.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $111.4M | 7,473,238 | 10.0% |
| Savara Inc(SVRA) | COM | 805111101 | $96.1M | 17,600,621 | 8.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $75.6M | 2,675,509 | 6.8% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $70.6M | 9,808,819 | 6.4% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $32.9M | 7,967,454 | 3.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $30.4M | 362,470 | 2.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $28.9M | 5,212,674 | 2.6% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $26.8M | 3,110,000 | 2.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $26.0M | 9,677,125 | 2.3% |
| Centessa Pharmaceuticals(CNTA) | SPONSORED ADS | 152309100 | $25.2M | 635,000 | 2.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $21.6M | 610,000 | 1.9% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $19.1M | 8,434,560 | 1.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $18.9M | 7,171,910 | 1.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $12.7M | 2,360,638 | 1.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $9.0M | 141,234 | 0.8% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $7.8M | 867,211 | 0.7% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T209 | $5.6M | 664,021 | 0.5% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $2.0M | 99,999 | 0.2% |